Cationic nanoemulsions are oil-in-water dispersions engineered with a positively charged interface that can associate with negatively charged RNA through electrostatic interactions. Their fluid oil core, tunable surfactant layer, and adjustable surface chemistry make them useful research carriers for mRNA, self-amplifying RNA, siRNA, miRNA, and other RNA formats. Successful development requires more than producing a small droplet size: the formulation must balance RNA association, colloidal stability, RNA protection, cellular interaction, cargo release, and acceptable performance in the intended experimental system.
Our cationic nanoemulsion RNA delivery services integrate formulation design, component screening, controlled RNA complexation, process optimization, physicochemical characterization, stability assessment, and cell-based functional testing. We support biotechnology companies, pharmaceutical research teams, CROs, academic laboratories, and platform developers that need decision-ready data for selecting, optimizing, or comparing nanoemulsion-based RNA delivery systems.
Figure 1. Squalene-based cationic nanoemulsion carriers, where mRNA is adsorbed to the surface by electrostatic binding. (Namit, C.; et al. 2021)
Incomplete RNA Association: RNA loading can remain inefficient when the cationic component-to-RNA ratio, mixing sequence, dilution conditions, or incubation time is poorly controlled. We evaluate complexation conditions and quantify free versus nanoemulsion-associated RNA to identify formulations that provide reproducible cargo association without unnecessary cationic material.
Droplet Destabilization After Loading: Adding RNA can change surface charge, increase droplet size, broaden the size distribution, or trigger aggregation. Our screening strategy evaluates the unloaded nanoemulsion and the final RNA complex separately, helping distinguish problems caused by the base formulation from those introduced during cargo loading.
Insufficient RNA Protection: A formulation may show high apparent loading while leaving RNA accessible to nucleases or damaging the cargo during processing. We combine integrity testing, nuclease-challenge studies, and formulation-condition reviews to determine whether the system protects functional RNA rather than merely binding it.
Low Functional Delivery: Strong electrostatic binding may improve association but restrict intracellular release, while excessive positive charge may reduce compatibility with cell-based models. We assess uptake, viability, reporter expression, gene silencing, or other project-relevant outputs to connect physicochemical properties with functional performance.
Poor Process Reproducibility: Nanoemulsion performance can shift with mixing energy, order of addition, temperature, concentration, buffer composition, and hold time. Our development plans emphasize controlled process parameters, batch comparability, and documented operating ranges so that promising formulations can be repeated and transferred more reliably.
Our service platform can support an entire cationic nanoemulsion project or a focused development stage. Programs are tailored to the RNA cargo, intended cell model, experimental endpoint, preferred component classes, and available comparator systems.
Clients may combine nanoemulsion development with our broader RNA drug delivery system services, mRNA delivery platform, or alternative lipid, polymer, and peptide-based carrier evaluations.
Figure 2. Preparation process of cationic nanoemulsions.
Figure 3. In vitro & in vivo validation of cationic nanoemulsion-mRNA.
Cationic nanoemulsions can be assembled through different loading and surface-engineering strategies. The most suitable format depends on RNA size, cargo stability, desired handling workflow, cell model, and whether the project prioritizes rapid cargo exchange, stronger protection, colloidal stability, or surface functionality.
| CNE Design Format | Best-Fit Research Need | Key Development Variables | Primary Evaluation Readouts | Common Development Risks |
| Post-Formation RNA Complex | Rapid loading of different RNA cargos onto a preformed positively charged nanoemulsion | Charge ratio, RNA addition rate, incubation time, final concentration, and buffer ionic strength | RNA association, size shift, PDI, zeta potential, RNA integrity, and functional delivery | Surface aggregation, incomplete association, weak nuclease protection, and cargo displacement after dilution |
| Controlled Co-Assembly | More integrated association of RNA during a controlled aqueous-phase assembly process | Mixing sequence, phase composition, shear or mixing energy, RNA exposure conditions, and process timing | Association efficiency, free RNA, morphology, batch reproducibility, and activity retention | RNA damage during processing, difficult process transfer, and sensitivity to small parameter changes |
| PEG-Modified CNE | Improved steric stabilization during storage, dilution, or exposure to complex media | PEG-lipid type, PEG density, insertion method, chain length, and cationic surface availability | Colloidal stability, surface charge, RNA loading, cell uptake, and functional output | Reduced RNA association or cellular interaction when PEG coverage is excessive |
| Ligand-Functionalized CNE | Research on receptor-mediated uptake or cell-selective carrier interaction | Ligand identity, coupling site, spacer length, surface density, orientation, and formulation compatibility | Ligand incorporation, receptor-dependent uptake, competitive binding, and expression or silencing | Steric obstruction, ligand loss, increased heterogeneity, and non-specific uptake |
| Responsive Cationic CNE | Evaluation of charge or release behavior that changes with pH or another experimental stimulus | Responsive amphiphile chemistry, transition range, cargo-binding strength, and buffer conditions | Charge profile, release or displacement behavior, intracellular trafficking, and functional delivery | Insufficient response under biological conditions, reduced storage stability, and complex optimization |
| Hybrid CNE Complex | Combining an oil-in-water nanoemulsion with polymeric, peptide, or additional lipid components | Assembly order, component compatibility, interfacial architecture, total positive charge, and cargo accessibility | Size distribution, structural stability, RNA protection, release, uptake, and functional activity | Multicomponent variability, difficult analytical interpretation, and increased aggregation risk |
No single analytical result establishes whether a cationic nanoemulsion is suitable for RNA delivery. Characterization should connect droplet properties, RNA condition, storage behavior, cell compatibility, and functional output. Decision criteria are therefore defined for each project rather than applying a universal particle-size or charge specification.
| Analysis Area | Why It Matters | Typical Approach | Decision Output | Development Stage |
| Droplet Size and PDI | Identifies aggregation, broad populations, and changes caused by RNA loading or storage | Dynamic light scattering before and after RNA association, dilution, or stress exposure | Formulation ranking and process-consistency assessment | Screening / Optimization |
| Zeta Potential | Tracks interfacial charge and helps interpret RNA binding, stability, and cell interaction | Electrophoretic light-scattering analysis of unloaded and RNA-loaded formulations | Charge-ratio selection and surface-composition adjustment | Screening / Optimization |
| RNA Association | Distinguishes efficiently complexed formulations from systems containing substantial free RNA | Fluorescence-based free-RNA assays, separation-based quantitation, or other cargo-appropriate methods | Loading-condition selection and dose-composition calculation | Screening / Confirmation |
| RNA Integrity | Determines whether emulsification, mixing, storage, or component exposure damages the cargo | Gel-based, capillary, chromatographic, or other RNA-format-appropriate analysis | Process-condition acceptance or redesign | Optimization / Stability |
| Nuclease Protection | Evaluates whether associated RNA remains protected under a defined enzymatic challenge | Nuclease exposure followed by RNA recovery and integrity or activity analysis | Protection ranking and surface-architecture refinement | Lead Selection |
| Colloidal Stability | Reveals aggregation, phase separation, charge drift, or RNA loss during storage and handling | Time-point monitoring under selected temperature, dilution, agitation, and freeze-thaw conditions | Storage recommendation and formulation-risk assessment | Optimization / Stability |
| Release and Displacement | Tests whether RNA can disengage from the carrier under conditions relevant to downstream activity | Dilution, competing-polyanion, pH-shift, or other project-defined release challenges | Balance between protection strength and cargo availability | Lead Selection |
| Morphology | Helps confirm droplet architecture and investigate unexpected size or stability results | Electron microscopy or another suitable imaging technique when required | Structural confirmation and troubleshooting support | Confirmation |
| Uptake and Viability | Determines whether increased cellular association is accompanied by acceptable cell compatibility | Flow cytometry, microscopy, viability assays, and dose-response evaluation | Working concentration range and formulation prioritization | Functional Evaluation |
| RNA Functional Output | Confirms that carrier uptake results in the intended intracellular RNA activity | Reporter expression, protein measurement, target-RNA analysis, or gene-silencing assays | Final lead selection and next-stage research recommendation | Functional Evaluation |
Our workflow links formulation decisions to measurable RNA-delivery outcomes. Individual stages can be adjusted according to whether the client needs early feasibility data, formulation optimization, analytical troubleshooting, functional comparison, or process-transfer support.
We define the RNA format, sequence length, concentration, modification pattern, supplied buffer, cell model, delivery endpoint, preferred components, comparator systems, and required deliverables. This step prevents formulation screening from being disconnected from the actual experimental objective.
Our team evaluates cargo sensitivity, likely loading strategy, component constraints, analytical requirements, and functional readouts. A screening matrix is then prepared with defined variables, controls, ranking logic, and progression criteria.
Candidate nanoemulsions are prepared across selected oil, surfactant, cationic component, and process conditions. RNA is introduced using controlled ratios and mixing sequences, followed by initial assessment of association, particle properties, appearance, and cargo integrity.
Promising candidates are refined by adjusting mixing energy, phase ratios, concentration, order of addition, incubation conditions, and final buffer. Repeat preparations are used to identify robust formulations rather than selecting a lead from a single batch.
Lead candidates undergo agreed physicochemical, RNA-protection, stability, uptake, viability, and cargo-specific functional testing. Results are interpreted together to determine whether high loading and cellular association translate into useful RNA activity.
We compile formulation compositions, process parameters, raw and processed data, analytical observations, lead-selection rationale, and recommended next steps. Where requested, the handoff can also include repeat-preparation instructions and considerations for larger-batch feasibility work.
Cationic nanoemulsion development requires coordinated expertise in RNA handling, colloidal formulation, electrostatic complexation, analytical characterization, and cell-based delivery evaluation. Our platform is structured to help clients understand why a formulation performs as it does and what should be changed before further research investment.
Cationic nanoemulsion systems can be adapted to multiple RNA formats, but every cargo requires its own loading, protection, release, and functional evaluation strategy. Our services support focused feasibility and development studies across the following research directions.
Whether you need an initial feasibility screen, a cargo-specific loading process, a complete formulation library, analytical troubleshooting, or comparative functional testing, our team can build a focused program around your RNA and research model. We support projects using client-supplied materials as well as workflows connected with RNA synthesis, modification, purification, and characterization. Contact us to discuss your cargo format, preferred formulation strategy, required assays, and project deliverables.
Cationic nanoemulsions demonstrate superior transfection efficiency with reduced cytotoxicity, offer enhanced stability profiles, and enable more cost-effective scale-up for research applications.
Squalene provides excellent biocompatibility as a natural hydrocarbon, enhances cellular uptake through optimized lipid composition, and improves formulation stability for consistent research outcomes.
Surfactant selection depends on charge density requirements, compatibility with mRNA molecules, cellular toxicity profiles, and specific application needs for targeted delivery efficiency.
Electrostatic binding to cationic droplet surfaces creates a protective barrier against nuclease degradation, while the oil core provides additional stabilization for sensitive mRNA molecules.
Loading ......
